NEW YORK, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that in the currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback